218 related articles for article (PubMed ID: 26024101)
1. Noninvasive vascular imaging of polypoidal choroidal vasculopathy by Doppler optical coherence tomography.
Miura M; Muramatsu D; Hong YJ; Yasuno Y; Iwasaki T; Goto H
Invest Ophthalmol Vis Sci; 2015 May; 56(5):3179-86. PubMed ID: 26024101
[TBL] [Abstract][Full Text] [Related]
2. Appearance of Polypoidal Lesions in Patients With Polypoidal Choroidal Vasculopathy Using Swept-Source Optical Coherence Tomographic Angiography.
Bo Q; Yan Q; Shen M; Song M; Sun M; Yu Y; Rosenfeld PJ; Wang F; Sun X
JAMA Ophthalmol; 2019 Jun; 137(6):642-650. PubMed ID: 30998817
[TBL] [Abstract][Full Text] [Related]
3. Differentiating Exudative Macular Degeneration and Polypoidal Choroidal Vasculopathy Using OCT B-Scan.
Kokame GT; Omizo JN; Kokame KA; Yamane ML
Ophthalmol Retina; 2021 Oct; 5(10):954-961. PubMed ID: 34022443
[TBL] [Abstract][Full Text] [Related]
4. Subfoveal choroidal thickness in polypoidal choroidal vasculopathy after switching to intravitreal aflibercept injection.
Saito M; Kano M; Itagaki K; Ise S; Imaizumi K; Sekiryu T
Jpn J Ophthalmol; 2016 Jan; 60(1):35-41. PubMed ID: 26350229
[TBL] [Abstract][Full Text] [Related]
5. Timing of Complete Polypoidal Regression after Intravitreous Aflibercept Treatments in Polypoidal Choroidal Vasculopathy.
Chaikitmongkol V; Upaphong P; Patikulsila D; Jirarattanasopa P; Choovuthayakorn J; Watanachai N; Kunavisarut P; Ratanasukon M; Bhurayanontachai P; Ingviya T; Bressler SB; Bressler NM
Ophthalmol Retina; 2022 Jan; 6(1):21-28. PubMed ID: 33781929
[TBL] [Abstract][Full Text] [Related]
6. Short-term efficacy of intravitreal aflibercept for patients with treatment-naïve polypoidal choroidal vasculopathy.
Ijiri S; Sugiyama K
Graefes Arch Clin Exp Ophthalmol; 2015 Mar; 253(3):351-7. PubMed ID: 25023147
[TBL] [Abstract][Full Text] [Related]
7. Non-ICGA treatment criteria for Suboptimal Anti-VEGF Response for Polypoidal Choroidal Vasculopathy: APOIS PCV Workgroup Report 2.
Chong Teo KY; Sadda SR; Gemmy Cheung CM; Chakravarthy U; Staurenghi G; Invernizzi A; Ogura Y; Ruamviboonsuk P; Chen SJ; Gupta V; Tan C; Chhablani J; Corvi F; Kim JE; Gomi F; Koh AH; Kokame G; Mitchell P; Wong TY; Lee WK; Lai TYY
Ophthalmol Retina; 2021 Oct; 5(10):945-953. PubMed ID: 33866022
[TBL] [Abstract][Full Text] [Related]
8. En-face high-penetration optical coherence tomography imaging in polypoidal choroidal vasculopathy.
Sayanagi K; Gomi F; Akiba M; Sawa M; Hara C; Nishida K
Br J Ophthalmol; 2015 Jan; 99(1):29-35. PubMed ID: 25107899
[TBL] [Abstract][Full Text] [Related]
9. Correlation of indocyanine green angiography and optical coherence tomography findings after intravitreal ranibizumab for polypoidal choroidal vasculopathy.
Ueno C; Gomi F; Sawa M; Nishida K
Retina; 2012; 32(10):2006-13. PubMed ID: 22772392
[TBL] [Abstract][Full Text] [Related]
10. En face imaging of the choroid in polypoidal choroidal vasculopathy using swept-source optical coherence tomography.
Alasil T; Ferrara D; Adhi M; Brewer E; Kraus MF; Baumal CR; Hornegger J; Fujimoto JG; Witkin AJ; Reichel E; Duker JS; Waheed NK
Am J Ophthalmol; 2015 Apr; 159(4):634-43. PubMed ID: 25528955
[TBL] [Abstract][Full Text] [Related]
11. Diagnosing Polypoidal Choroidal Vasculopathy Using Color Fundus Photography, Optical Coherence Tomography, and Optical Coherence Tomography Angiography.
Park S; Lee J; Park JB; Kim ES; Yu SY; Kang MS; Kim K
Korean J Ophthalmol; 2023 Dec; 37(6):468-476. PubMed ID: 37899281
[TBL] [Abstract][Full Text] [Related]
12. One-Year Results of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy.
Yamamoto A; Okada AA; Kano M; Koizumi H; Saito M; Maruko I; Sekiryu T; Iida T
Ophthalmology; 2015 Sep; 122(9):1866-72. PubMed ID: 26088619
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of polypoidal lesion-selective photodynamic therapy with intravitreal antivascular endothelial growth factor for polypoidal choroidal vasculopathy.
Komuku Y; Iwahashi C; Gomi F
Jpn J Ophthalmol; 2020 May; 64(3):265-270. PubMed ID: 32206935
[TBL] [Abstract][Full Text] [Related]
14. OPTICAL COHERENCE TOMOGRAPHY FEATURES OF POLYPOIDAL LESION CLOSURE IN POLYPOIDAL CHOROIDAL VASCULOPATHY TREATED WITH AFLIBERCEPT.
Tan ACS; Jordan-Yu JM; Vyas CH; Gan ATL; Teo KYC; Chan CM; Mathur R; Wong TY; Chakravarthy U; Cheung GCM
Retina; 2022 Jan; 42(1):114-122. PubMed ID: 34412103
[TBL] [Abstract][Full Text] [Related]
15. ONE-YEAR RESULTS OF INTRAVITREAL AFLIBERCEPT FOR POLYPOIDAL CHOROIDAL VASCULOPATHY.
Hara C; Sawa M; Sayanagi K; Nishida K
Retina; 2016 Jan; 36(1):37-45. PubMed ID: 26383709
[TBL] [Abstract][Full Text] [Related]
16. Six-month results of intravitreal aflibercept injections for patients with polypoidal choroidal vasculopathy.
Hosokawa M; Shiraga F; Yamashita A; Shiragami C; Ono A; Shirakata Y; Kimura S; Shiode Y; Kawata T; Hosogi M; Fujiwara A; Morizane Y
Br J Ophthalmol; 2015 Aug; 99(8):1087-91. PubMed ID: 25712826
[TBL] [Abstract][Full Text] [Related]
17. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF POLYPOIDAL CHOROIDAL VASCULOPATHY AND POLYPOIDAL CHOROIDAL NEOVASCULARIZATION.
Inoue M; Balaratnasingam C; Freund KB
Retina; 2015 Nov; 35(11):2265-74. PubMed ID: 26405770
[TBL] [Abstract][Full Text] [Related]
18. A Comparison Study of Polypoidal Choroidal Vasculopathy Imaged with Indocyanine Green Angiography and Swept-Source Optical Coherence Tomography Angiography.
Kim K; Yang J; Feuer W; Gregori G; Kim ES; Rosenfeld PJ; Yu SY
Am J Ophthalmol; 2020 Sep; 217():240-251. PubMed ID: 32445699
[TBL] [Abstract][Full Text] [Related]
19. Association between the arm-to-choroidal circulation time and clinical profile in patients with polypoidal choroidal vasculopathy.
Mukai R; Itagaki K; Honjyo J; Tanaka K; Norikawa K; Sekiryu T
Jpn J Ophthalmol; 2024 May; 68(3):211-215. PubMed ID: 38609716
[TBL] [Abstract][Full Text] [Related]
20. Small dome-shaped pigment epithelium detachment in polypoidal choroidal vasculopathy: an under-recognized sign of polypoidal lesions on optical coherence tomography?
Wang Y; Bo Q; Jia H; Sun M; Yu Y; Huang P; Wang J; Xu N; Wang F; Wang H; Sun X
Eye (Lond); 2022 Apr; 36(4):733-741. PubMed ID: 33833415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
